As coronavirus is still raging around the world, Latin America is signing up for phase 3 vaccine trials by American pharma giant Johnson&Johnson.

According to the company, two new candidate countries want to sign up for testing a new vaccine on their citizens, and these are Argentina and Chile.

So far, the pharma giant signed vaccine testing contracts with Mexico, Brazil, Colombia, and Peru.

As of last night, there are two more Latin American countries to join the trials and contribute to the faster development of the COVID-19 vaccine.

The study is scheduled for September, and all of these countries were chosen because of their high infection rates.

However, the pharma giant is still waiting for official governmental approvals to conduct the trials and provide relevant data by the end of this year.

The trial in Chile will be conducted by the University of Chile’s School of Medicine, ready to recruit over 1,000 people for the vaccine testing.

The Colombian President Duque also confirmed the participation in the phase 3 trials with Johnson&Johnson.

The pharma giant officials said, “The current prevalence of the disease, the demographics of the population, and the requirements of the health authorities were taken into account to ensure that the study can be carried out properly and provide relevant data.”